» Articles » PMID: 12120259

New Horizons--alternative Routes for Insulin Therapy

Overview
Specialty Pharmacology
Date 2002 Jul 18
PMID 12120259
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Since the introduction of insulin therapy 80 years ago, the lives of millions of patients with diabetes have been saved, prolonged and immeasurably improved. However, restoring normal glucose levels in diabetic patients through administering insulin by subcutaneous injection has proved virtually impossible. The consequences for patients are serious complications, including diabetic retinopathy and nephropathy, which tend to result from persistent hyperglycaemia. Maximizing glucose control in diabetic patients requires several daily injections. In an effort to reduce this burden, alternative and less-intrusive routes for the administration of insulin are being explored.

Citing Articles

Low-dose intrapulmonary drug delivery device for studies on next-generation therapeutics in mice.

Gracioso Martins A, Snider D, Popowski K, Schuchard K, Tenorio M, Akunuri S J Control Release. 2023; 359:287-301.

PMID: 37301267 PMC: 10527740. DOI: 10.1016/j.jconrel.2023.05.039.


Mucoadhesive Dendrons Conjugated to Mesoporous Silica Nanoparticles as a Drug Delivery Approach for Orally Administered Biopharmaceuticals.

Tollemeto M, Huang Z, Christensen J, Nielsen H, Ronholt S ACS Appl Mater Interfaces. 2023; .

PMID: 36749788 PMC: 9951175. DOI: 10.1021/acsami.2c16502.


Insulin: evolution of insulin formulations and their application in clinical practice over 100 years.

Bolli G, Cheng A, Owens D Acta Diabetol. 2022; 59(9):1129-1144.

PMID: 35854185 PMC: 9296014. DOI: 10.1007/s00592-022-01938-4.


Identifying signatures of proteolytic stability and monomeric propensity in O-glycosylated insulin using molecular simulation.

Hsu W, Ramirez D, Sammakia T, Tan Z, Shirts M J Comput Aided Mol Des. 2022; 36(4):313-328.

PMID: 35507105 PMC: 10353491. DOI: 10.1007/s10822-022-00453-6.


Radiolabeling Method for Lyophilizate for Dry Powder Inhalation Formulations.

Miyamoto K, Akita T, Yamashita C Pharmaceutics. 2022; 14(4).

PMID: 35456593 PMC: 9033134. DOI: 10.3390/pharmaceutics14040759.